4//SEC Filing
Moxie Dwight 4
Accession 0001479290-24-000016
CIK 0001479290other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 4:48 PM ET
Size
7.8 KB
Accession
0001479290-24-000016
Insider Transaction Report
Form 4
Moxie Dwight
CLO & GC
Transactions
- Award
Performance Stock Units
2024-01-31+135,000→ 135,000 totalFrom: 2025-02-15Exp: 2028-01-31→ Common Stock (135,000 underlying) - Award
Common Stock
2024-01-31+90,000→ 134,066 total
Footnotes (3)
- [F1]The shares subject to the Restricted Stock Unit shall vest in three (3) equal annual installments beginning from February 15, 2025, subject to the reporting person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) on each vesting date.
- [F2]The performance-based RSUs (PSUs) granted to the reporting person on January 31, 2024, represent the right to receive, following vesting, a number of shares of Common Stock up to 150% of the number of PSUs. The number of shares of Common Stock acquired upon vesting of the PSUs is contingent upon the achievement of a preestablished performance metric, as approved by the Company's Compensation Committee, over a four-year performance period, subject to time based service requirements and continuous employment with the Company through the vesting dates.
- [F3]The number of securities reported represents the maximum shares that can be earned.
Documents
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeother
Related Parties
1- filerCIK 0001803375
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 4:48 PM ET
- Size
- 7.8 KB